Meeting
2018 ASCO Annual Meeting
PET scan-directed chemoradiation (CRT) for esophageal squamous cell carcinoma (ESCC): No benefit for salvage chemo in PET non-responders (PETnr).
Authors
Megan Greally
Memorial Sloan Kettering Cancer Center, New York, NY
Megan Greally , Joanne F. Chou , Daniela Molena , Valerie W. Rusch , Manjit S. Bains , Bernard J. Park , Abraham Jing-Ching Wu , David Paul Kelsen , Yelena Yuriy Janjigian , David H. Ilson , Geoffrey Yuyat Ku
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 4055)
DOI
10.1200/JCO.2018.36.15_suppl.4055
Abstract #
4055
Poster Bd #
244
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.
First Author: Michele Reni
Poster
2015 Gastrointestinal Cancers Symposium
Novel chemotherapy combinations for metastatic gastric adenocarcinoma (mAGC): An updated meta-analysis.
First Author: Anna Dorothea Wagner
Poster
2014 Gastrointestinal Cancers Symposium
FDG-PET scan after induction chemotherapy for esophageal squamous cell cancer (ESCC) to predict for outcomes after chemoradiation (chemoRT) and to guide salvage chemotherapy during RT.
First Author: Geoffrey Yuyat Ku
Poster
2023 ASCO Annual Meeting
Induction chemotherapy plus definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: Long-term results and exploratory analyses of a randomized controlled trial.
First Author: Mian Xi